Earnings results for ANCHIANO THERAP/S (NASDAQ:ANCN)
Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingJun 2020 , the consensus EPS* forecast has remained the same over the past week at -0.55 and remained the same over the past month at -0.55. none raised and none lowered their forecast. For the fiscal year ending Dec 2020 , the consensus EPS* forecast has remained the same over the past week at -2.25 and remained the same over the past month at -2.25 . none raised and none lowered their forecast.
ANCHIANO THERAP/S last posted its quarterly earnings results on May 7th, 2020. The reported ($0.41) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.14. ANCHIANO THERAP/S has generated ($3.46) earnings per share over the last year. ANCHIANO THERAP/S has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, August 10th, 2020 based off prior year’s report dates.
Analyst Opinion on ANCHIANO THERAP/S (NASDAQ:ANCN)
3 Wall Street analysts have issued ratings and price targets for ANCHIANO THERAP/S in the last 12 months. Their average twelve-month price target is $16.00, suggesting that the stock has a possible upside of 1,381.48%. The high price target for ANCN is $16.00 and the low price target for ANCN is $16.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of “Hold.”
ANCHIANO THERAP/S has received a consensus rating of Hold. The company’s average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings. According to analysts’ consensus price target of $16.00, ANCHIANO THERAP/S has a potential upside of 1,381.5% from its current price of $1.08. ANCHIANO THERAP/S has received no research coverage in the past 90 days.
Dividend Strength: ANCHIANO THERAP/S (NASDAQ:ANCN)
ANCHIANO THERAP/S does not currently pay a dividend. ANCHIANO THERAP/S does not have a long track record of dividend growth.
Insiders buying/selling: ANCHIANO THERAP/S (NASDAQ:ANCN)
In the past three months, ANCHIANO THERAP/S insiders have not sold or bought any company stock. Only 6.88% of the stock of ANCHIANO THERAP/S is held by insiders. Only 7.49% of the stock of ANCHIANO THERAP/S is held by institutions.
Earnings and Valuation of ANCHIANO THERAP/S (NASDAQ:ANCN
Earnings for ANCHIANO THERAP/S are expected to decrease in the coming year, from ($2.25) to ($3.00) per share. The P/E ratio of ANCHIANO THERAP/S is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of ANCHIANO THERAP/S is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. ANCHIANO THERAP/S has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.
More latest stories: here